The independent source for health policy research, polling, and news.
881 - 900 of 112,362 Results
One noted exception to the finding that agency leaders largely adhered to the evidence-based recommendations of scientists happened during the first Trump term, while covid restrictions were in place, when agency brass declined to lift a required in-person visit to acquire mifepristone.
The Senate report does not accuse UnitedHealth of wrongdoing, but it describes in detail how the company used artificial intelligence and other data-mining techniques to scan patient medical records for new diagnoses and “appears to use all of these mechanisms to the utmost degree." A UnitedHealth spokesman said the company disagreed with the Senate report’s characterizations.
The letter from medical groups and public health organizations urged lawmakers to prove "why the schedule was changed, why credible scientific evidence was ignored, and why the committee charged with advising the HHS secretary on immunizations did not discuss the schedule changes as a part of their public meeting process."
AbbVie has pledged to put $100 billion toward research, development, and capital investments. Regeneron Pharmaceuticals is the only one of 17 drugmakers that hasn't reached a deal with the government to avoid tariffs. Other news looks at FDA vouchers, ACA enrollment, and more.
The Department of Health and Human Services' decision to cut off funding to the group was likely retaliatory in nature, a federal judge ruled. The grants will be restored while the academy's lawsuit plays out in court. Also, the Trevor Project receives a $45 million lifeline.
Today's early morning highlights from the major news organizations.
A federal judge suspended the administration's block on federal aid to five Democratic states while their lawsuit winds through the courts. Meanwhile, lawmakers are working together to advance legislation to rescind funding cuts for scientific research. Plus, news outlets unpack health guidance.
Opinion writers examine these public health issues.
The long-awaited study, which was commissioned by the FDA in hopes of reducing racial bias, found results that contradict past research findings, leaving clinicians confused. Also: FDA Commissioner Marty Makary's effort to speed drug reviews faces scrutiny; researchers look to LSD as an anxiety treatment; and more.
Over a year ago, Planned Parenthood sued to overturn Missouri's abortion ban, stating the restrictions were unconstitutional. Circuit Judge Jerri Zhang will hear the case this week.
New contract provisions on AI and workplace violence, along with salary increases to keep up with inflation, are among their demands. Also, Texas joins 17 other states making it easier for foreign doctors to work legally without repeating their residencies.
States typically rely on the CDC for guidance on immunizations, and school systems take their cues from their states. The politicization of this particular health care policy is sowing confusion, leaving both to make their own determinations about vaccine mandates. Plus, viruses are on the rise.
President Donald Trump made the comment aboard Air Force One on Sunday. Other ACA news is on Ohio Sen. Bernie Moreno's role in the subsidy talks, the prospect of marrying to obtain more affordable health care, and more.
Today's early morning highlights from the major news organizations.
Editorial writers tackle these public health topics.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on insurance denials, seniors who overmedicate, mental health, and more.
Researchers determined eligibility requirements mandated in the One Big Beautiful Bill would lead to nearly 1.2 million missed colorectal, breast, or lung cancer screenings and 155 preventable deaths within two years, Stat reported. Plus, a reshaped health care sector copes with new regulations.
The 2 Care program will serve about 2,000 children when it opens later this year and will be paid for with existing state funds for the next fiscal year, Mayor Zohran Mamdani and Gov. Kathy Hochul announced Thursday. Other news comes from Connecticut, Hawaii, Louisiana, Texas, Rhode Island, and Massachusetts.
The large nonprofit health system, based in Philadelphia, is suing multiple companies, saying they colluded to raise the price of insulin, which in turn forced the health system to spend more on patient care. In separate statements, the three main PBMs at the center of the lawsuit — CVS Caremark, Express Scripts, and Optum Rx — denied the allegations, Health Exec reported.
The bill that gained the support of 17 House Republicans would renew premium tax credits for three years. A bipartisan group of lawmakers is hopeful that some of the GOP sticking points will be ironed out soon. Plus, insurers are being called to Capitol Hill to answer questions about health care costs.
© 2026 KFF